Brief: Rua Bioscience Commences Legal Proceedings Against Cann Group
15/02/2024 01:14
Feb 15 (Reuters) - Rua Bioscience Ltd RUA.NZ :
* COMMENCES LEGAL PROCEEDINGS AGAINST CANN GROUP
* PROCEEDINGS CLAIMING DAMAGES FOR BREACH OF CONTRACTUAL
RIGHTS TO
EXCLUSIVELY SELL CANN'S MEDICINAL CANNABIS PRODUCTS IN AUSTRALIA
* OF VIEW THAT BREACHES ON AN EXCLUSIVE SUPPLY TERM PROVIDED
FOR
IN SUPPLY CONTRACT HAVE CAUSED RUA TO SUFFER SIGNIFICANT DAMAGES
Source text for Eikon: ID:n426252-2
Further company coverage: RUA.NZ
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Reports Research Partnership To Develop Smoking Cessation Products
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising